|
Volumn 145, Issue 4, 2008, Pages 483-486
|
Gene therapy of amyotrophic lateral sclerosis
a b a c d a a a d d d d d a a d |
Author keywords
Adenoviral vector; Amyotrophic lateral sclerosis; Angiogenin; Gene therapy; VEGF
|
Indexed keywords
ADENOVIRUS VECTOR;
ANGIOGENIN;
PLACEBO;
VASCULOTROPIN;
ADULT;
AMYOTROPHIC LATERAL SCLEROSIS;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG FEVER;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GENE EXPRESSION;
HUMAN;
HUMAN CELL;
INFLUENZA;
MALE;
MOTONEURON;
NEUROTROPISM;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
SYSTEMIC DISEASE;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
VIRUS RECOMBINANT;
ADENOVIRIDAE;
ADULT;
AMYOTROPHIC LATERAL SCLEROSIS;
ANGIOTENSINOGEN;
CELLS, CULTURED;
FEMALE;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
MALE;
MIDDLE AGED;
PLACEBOS;
TRANSGENES;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
HUMAN ADENOVIRUS;
|
EID: 55649119587
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1007/s10517-008-0124-4 Document Type: Article |
Times cited : (13)
|
References (7)
|